A quick update here. LongCovidLabs announced today they are starting their first clinical trial using pemgarda. Exciting news! If you don't know anything about them, their founder suffered from long covid for 2 and 1/2 years before combining paxlovid and monoclonal antibodies, which he says cured him of long covid. Check the about page on their site below.

https://www.longcovidlabs.org/post/announcing-our-first-clinical-trial

We’re thrilled to launch our first clinical trial at Long COVID Labs, focused on testing a promising combination of two therapeutics: Pemgarda and Paxlovid. Both medications offer unique mechanisms that target SARS-CoV-2 differently, and this combination treatment could represent a new frontier in addressing persistent viral symptoms for Long COVID patients.